Neutrophil-to-lymphocyte ratio and the systemic immune-inflammation index as potential biomarkers of effective treatment and subclinical atherosclerotic cardiovascular disease in patients with psoriasis
J Eur Acad Dermatol Venereol
.
2023 May;37(5):e586-e589.
doi: 10.1111/jdv.18860.
Epub 2023 Jan 21.
Authors
Amanda Kvist-Hansen
1
2
,
Hannah Kaiser
1
2
,
Martin Krakauer
3
,
Peter M Gørtz
4
,
Xing Wang
5
,
Christine Becker
5
6
,
Claus Zachariae
1
7
,
Peter R Hansen
2
7
,
Lone Skov
1
7
Affiliations
1
Department of Dermatology and Allergy, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark.
2
Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark.
3
Department of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark.
4
Department of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark.
5
Division of Clinical Immunology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
6
Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
7
Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
PMID:
36645810
DOI:
10.1111/jdv.18860
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Biomarkers
Cardiovascular Diseases* / etiology
Humans
Inflammation
Lymphocytes
Neutrophils
Psoriasis* / complications
Psoriasis* / drug therapy
Substances
Biomarkers
Grants and funding
LF16115/LEO Fondet